ofloxacin has been researched along with erythromycin in 171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (3.51) | 18.7374 |
| 1990's | 50 (29.24) | 18.2507 |
| 2000's | 68 (39.77) | 29.6817 |
| 2010's | 40 (23.39) | 24.3611 |
| 2020's | 7 (4.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, M; Kawabata, S; Kohno, S; Nakamura, T; Nakatomi, K; Noguchi, Y; Oka, M; Shiozawa, K; Soda, H; Suenaga, M; Tei, C; Terashi, K; Tsukamoto, K | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Mima, T; Schweizer, HP | 1 |
| Goswami, M; Jawali, N | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Bekker, OB; Charushin, VN; Danilenko, VN; Ignatenko, NK; Ishmetova, RI; Korotina, AV; Maslov, DA; Rusinov, GL; Shur, KV; Tolshchina, SG; Vatlin, AA | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
| Lei, M; Lu, X; Tang, W; Wu, C; Xie, Y; Zha, L; Zhang, J | 1 |
| Kirchner, JT | 1 |
| Bebear, C; Renaudin, H | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Hammerschlag, MR; Qumei, KK; Roblin, PM | 1 |
| Chidiac, C; Mouton, Y; Senneville, E | 1 |
| Dailloux, M; Villemain, P | 1 |
| Hooton, TM; Lipsky, BA; Pecoraro, RE; Peugeot, RL | 1 |
| Cartwright, FD; Kenny, GE | 1 |
| Børsum, T; Dannevig, L; Melby, K; Størvold, G | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
| From, E; Halkier-Sørensen, L; Herrmann, B; Ibsen, HH; Mårdh, PA; Møller, BR | 1 |
| Grayston, JT; Kuo, CC; Lipsky, BA; Tack, KJ; Wang, SP | 1 |
| Garcia, JG; Griffith, DE; Kohler, RB; Stocks, JM; Wallace, RJ | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Baskerville, A; Featherstone, AS; Fitzgeorge, RB | 1 |
| Debbia, E; Gianrossi, G; Mannelli, S; Schito, GC | 1 |
| Carlstedt-Duke, B; Høverstad, T; Lingaas, E; Midtvedt, T; Norin, KE; Saxerholt, H; Steinbakk, M | 1 |
| Ogawa, H; Osada, Y | 1 |
| Baltch, AL; Ritz, W; Smith, RP | 1 |
| Ikeda, N | 1 |
| Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
| Discepola, MJ; Goldstein, DA; Jackson, WB; Kirsch, LS | 1 |
| Bru, JP; Gaillat, J; Sedallian, A | 1 |
| Dailloux, M; Grignon, G; Kohler, C; Laurain, C; Le Faou, A | 1 |
| Akamatsu, H; Akamatsu, M; Asada, Y; Kurokawa, I; Nishijima, S | 1 |
| Frottier, J; Kirstetter, M; Matsiota-Bernard, P; Nauciel, C; Salord, JM; Staïkowsky, F | 1 |
| Butzler, JP; Goldhar, J; Goossens, H; Levy, J; Schwartz, D | 1 |
| Bébéar, C; de Barbeyrac, B; Dewilde, A; Edert, D; Janvresse, C; Layani, MP; Le Faou, A; Lefèvre, JC; Mendel, I; Renaudin, H | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Akashi, A; Arai, S; Furudera, T; Gohara, Y; Kuwano, K; Matsubara, S; Matumoto, M; Tseng, CC | 1 |
| Egede, F; Husfeldt, P; Nielsen, PB | 1 |
| Morrissey, I; Smith, JT | 1 |
| Fujimura, M; Ishiura, Y; Matsuda, T; Nakatsumi, Y; Nomura, M; Saito, M; Shibata, K | 2 |
| Kawahara, S; Matsuka, Y; Sato, T; Takahashi, K; Watanabe, Y | 1 |
| Aleksandrova, AE; Vinogradova, TI | 1 |
| Askienazy-Elbhar, M; Bianchi, A; Joly-Guillou, ML; Lefevre, JC; Legouge, R; Pavis, A; Sednaoui, P | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S | 1 |
| Amiel, C; Baty, V; Canton, P; Garin, H; Hoen, B; Reyrolle, M; Schuhmacher, H | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Hammerschlag, MR; Kutlin, A; Roblin, PM | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 1 |
| Baltch, AL; Franke, M; Hioe, W; Michelsen, P; Ritz, W; Smith, RP | 1 |
| Arnold, B; Stout, JE; Yu, VL | 1 |
| Hammerschlag, MR; Roblin, PM | 1 |
| Arakaki, N; Higa, F; Kawakami, K; Kusano, N; Saito, A; Shinzato, T; Tateyama, M | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Colsky, AS; Kerdel, FA; Kirsner, RS | 1 |
| Farooqui, BJ; Nizami, SQ | 1 |
| Baltch, AL; Franke, MA; Michelsen, PB; Smith, RP | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Bébéar, C; Bébéar, CM; Leblanc, F; Renaudin, H; Schaeverbeke, T | 1 |
| Krausse, R; Schubert, S; Ullmann, U | 1 |
| Potts, JM; Rackley, RR; Ward, AM | 1 |
| Matsumoto, A; Matsushima, T; Miyashita, N | 1 |
| Baltch, AL; Franke, MA; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
| Azimi, PH; Brenner, RA; Clark, P; Clemens, J; Gill, V; Lin, FY; Philips, JB; Pratt, E; Regan, J; Rhoads, GG; Troendle, J; Weisman, LE | 1 |
| Chuang, AZ; Hashemi, K; Lanier, JD; Schweitzer, C | 1 |
| Gotoh, N; Masuda, N; Nishino, T; Ohya, S; Sakagawa, E; Tsujimoto, H | 1 |
| Bebear, C; Bebear, CM; Charron, A; Gruson, D; Lefrancois, M; Renaudin, H | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
| Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
| Dunbar, L; Fogarty, CM; Greenberg, RN; Kojak, CM; Marrie, TJ; Morgan, N; Player, R; Williams, RR | 1 |
| Choi, CH; Kim, HS; Min, YD | 1 |
| Chuma, T; Ikeda, T; Maeda, T; Niwa, H; Okamoto, K | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Hayashi, K; Mitsuyama, J; Yamakawa, T | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Fukuda, M; Sasaki, K | 1 |
| Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M | 1 |
| Metlay, JP | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Califf, RM; Curtis, LH; Dans, PE; Hutchison, S; Schulman, KA; Sendersky, V; Usdin Yasuda, S; Woosley, RL; Wright, A; Østbye, T | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Domingues, D; Duarte, A; Exposto, F; Prieto, E; Sanca, A; Távora Tavira, L | 1 |
| Bisquert Santiago, J; Gimeno Fernández, C; González Praetorius, A; Pérez Pomata, MT; Robres Guillén, P; Rodríguez-Zurita, ME; Solís del Baño, S | 1 |
| Chuma, T; Itoh, K; Niwa, H; Okamoto, K | 1 |
| Arakaki, N; Higa, F; Kawakami, K; Koide, M; Saito, A; Shinzato, T; Tateyama, M | 1 |
| Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M | 1 |
| Basar, H; Basar, MM; Batislam, E; Kaygusuz, S; Kilic, D; Yilmaz, E | 1 |
| Chen, ZM; Hua, CZ; Li, JP; Shang, SQ; Sun, XF; Yu, XL | 1 |
| Arda, B; Gökengin, D; Gürel, O; Tunçel, M; Yaimazhan, T | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| Brown, SD; Farrell, DJ; Morrissey, I | 1 |
| Bonfiglio, G; Lanzafame, A; Mattina, R; Santini, L | 1 |
| Gong, X; Mabey, D; Shang, S; Wang, Q; Xia, L; Zhang, J; Zhao, J; Zhong, M | 1 |
| Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
| Arnold, FW; Wojda, B | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 2 |
| Carroll, S; Goonetilleke, A; Hargreaves, M | 1 |
| Kilic, B; Kruse, M; Stahlmann, R | 1 |
| Caniça, M; Dias, R; Louro, D | 1 |
| Coll, P; Gurguí, M; Mateo, M; Mirelis, B; Miró, E; Navarro, F; Rebollo, M; Rivera, A | 1 |
| Li, XD; Liu, YC; Xu, WH; Zhang, G; Zou, SC | 1 |
| Benzonana, NA; Ozer, S; Oznur, AK | 1 |
| Flick, B; Kilic, B; Kruse, M; Stahlmann, R | 1 |
| Mondschein, JI; Patel, S; Soulen, MC; Tuite, CM | 1 |
| Di Conza, J; Massa, R; Méndez, E; Mollerach, A | 1 |
| Benninger, MS; Brown, NP; Evangelista, AT; Sahm, DF; Thornsberry, C; Yee, YC | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Hu, J; Liu, H; Liu, X; Wang, G; Xie, L | 1 |
| Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
| Ness, RB; Roberts, MS; Smith, KJ; Wiesenfeld, HC | 1 |
| Arija, V; Bejarano-Romero, F; Cliville-Guasch, X; de Diego, C; Gomez-Bertomeu, F; Ochoa-Gondar, O; Raga-Luria, X; Salsench, E; Vila-Corcoles, A | 1 |
| Billal, DS; Fedorko, DP; Fujihara, K; Hotomi, M; Shimada, J; Yamanaka, N; Yan, SS | 1 |
| Bernardin, G; Cua, E; de Salvador, F; Dellamonica, J; Hyvernat, H; Landraud, L; Risso, K; Roger, PM; Vassallo, M | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| del Carmen Ponte, M; del Prado, G; Naves, P; Rodríguez-Cerrato, V; Ruiz, V; Soriano, F | 1 |
| Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A | 1 |
| Liu, JY; Luo, DQ; Wu, YM; Yang, W; Yu, MJ; Zhang, B | 1 |
| Lam, JC; Lam, PK; Leung, HW; Martin, M; Minh, TB; Murphy, MB; Richardson, BJ; So, MK | 1 |
| Dan, M; Rosenberg, S; Samra, Z | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Adlan, E; Farkas, B; Kárpáti, S; Marschalkó, M; Ostorházi, E; Párducz, L; Pónyai, K; Rozgonyi, F; Tóth, B | 1 |
| Amicosante, G; Bellio, P; Brisdelli, F; Celenza, G; Garbarino, JA; Nicoletti, M; Perilli, M; Piovano, M; Segatore, B; Setacci, D | 1 |
| Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
| Bijlsma, JJ; Canton, E; Gant, CM; González-Morán, F; López-Hontangas, JL; Rosingh, AW; van der Heijden, M | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Cao, B; Chu, Y; He, W; Hu, B; Hu, Z; Liao, K; Mei, Y; Ni, Y; Sun, Z; Wang, H; Xu, Y; Yang, Q; Yu, Y; Zhang, F; Zhang, L; Zhao, C | 1 |
| Rakoto Alson, AO; Rasamindrakotroka, A; Rasamiravaka, T; Rasoanandrasana, S; Zafindraibe, NJ | 1 |
| Görner, T; Hassenboehler, L; Merlin, C; Munoz, JF; Pasquini, L; Pons, MN | 1 |
| Dauchy, X; France, X; France-Lanord, C; Görner, T; Le, ND; Munoz, JF; Pasquini, L; Pons, MN; Yvon, J | 1 |
| Igbinosa, IH | 1 |
| Bodmer, T; Donà, V; Droz, S; Endimiani, A; Hilty, M; Schneider, SC; Tinguely, R | 1 |
| Dang, Z; Huang, RP; Liu, ZH; Yin, H; Yuan, SF | 1 |
| Khan, A; Koenekoop, RK; Mikhail, M | 1 |
| Alcaraz, I; Caumes, E; Dupin, N; Janier, M; Maatouk, I; Timsit, FJ | 1 |
| Barceló, D; Blánquez, P; Hom-Diaz, A; Jaén-Gil, A; Llorca, M; Rodríguez-Mozaz, S; Vicent, T | 1 |
| Ormeno-Cano, N; Radjenovic, J | 1 |
| Cao, Z; Li, X; Lu, Y; Mao, R; Song, S; Sun, B; Wang, C; Wang, R; Zhang, M | 1 |
| Arun, S; Chakraborty, P; Gaonkar, O; Neppolian, B; Xin, L; Zhang, G | 1 |
| Fazeli, MR; Sepahi, AA; Shariatmadari, F; Zamani, N | 1 |
| Chen, Y; Cui, K; Ding, Y; Liu, X; Qin, X | 1 |
| Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL | 1 |
2 review(s) available for ofloxacin and erythromycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro Techniques; Legionnaires' Disease; Ofloxacin; Pefloxacin; Pneumonia, Mycoplasma | 1992 |
15 trial(s) available for ofloxacin and erythromycin
| Article | Year |
|---|---|
Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycin.
Topics: Adult; Aged; Bronchitis; Chlamydia Infections; Erythromycin; Female; Humans; Legionnaires' Disease; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Pneumonia; Pneumonia, Mycoplasma; Respiratory Tract Infections | 1991 |
Occurrence of Ureaplasma urealyticus and Mycoplasma hominis in non-gonococcal urethritis before and after treatment in a double-blind trial of ofloxacin versus erythromycin.
Topics: Double-Blind Method; Erythromycin; Humans; Male; Mycoplasma; Mycoplasma Infections; Mycoplasmatales Infections; Ofloxacin; Prospective Studies; Ureaplasma; Urethritis | 1990 |
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.
Topics: Aged; Bronchitis; Chlamydia; Chlamydia Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Humans; Male; Middle Aged; Ofloxacin; Pneumonia; Respiratory Tract Infections; Retrospective Studies | 1990 |
Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
Topics: Adult; Amoxicillin; Bronchitis; Erythromycin; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sputum | 1989 |
Perioperative ofloxacin vs. tobramycin: efficacy in external ocular adnexal sterilization and anterior chamber penetration.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Aqueous Humor; Bacteria; Conjunctiva; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Eyelids; Female; Humans; Male; Middle Aged; Ofloxacin; Ointments; Ophthalmic Solutions; Sterilization; Tobramycin | 1995 |
Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Drug Tolerance; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillin G; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Streptococcus pneumoniae; Treatment Outcome | 1994 |
Antibiotic treatment of sinusitis in general practice. A double-blind study comparing ofloxacin and erythromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Erythromycin; Family Practice; Female; Humans; Male; Middle Aged; Ofloxacin; Sinusitis; Treatment Outcome | 1993 |
Additive effect of continuous low dose ofloxacin on erythromycin therapy for sinobronchial syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Sinusitis; Sputum; Syndrome | 1995 |
Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Cross-Over Studies; Erythromycin; Female; Humans; Male; Middle Aged; Ofloxacin; Respiratory Tract Infections; Sputum | 1995 |
Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Carbocysteine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Humans; Japan; Male; Middle Aged; Ofloxacin; Sinusitis; Syndrome | 1995 |
Comparison of antibiotic drops placed in the conjunctival cul-de-sac to antibiotic ointment applied to the lid margin in reduction of bacterial colonization on the lid margin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacitracin; Bacteria; Colony Count, Microbial; Conjunctiva; Drug Resistance, Microbial; Erythromycin; Eye Infections, Bacterial; Eyelid Diseases; Eyelids; Female; Gentamicins; Humans; Male; Middle Aged; Ofloxacin; Ointments; Ophthalmic Solutions; Prospective Studies; Single-Blind Method | 2000 |
Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Ofloxacin; Pneumonia, Pneumococcal | 2001 |
Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiolitis; Bronchitis; Drug Therapy, Combination; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Sinusitis; Syndrome; Treatment Outcome | 2002 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
154 other study(ies) available for ofloxacin and erythromycin
| Article | Year |
|---|---|
Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Interactions; Erythromycin; Fluoresceins; Genes, MDR; Humans; Leukemia; Ofloxacin; Tumor Cells, Cultured; Vincristine | 2000 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Erythromycin; Heterocyclic Compounds, 2-Ring; Imidazoles; Imipenem; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Protein Serine-Threonine Kinases; Rifampin | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
Novel benzothiazole‒urea hybrids: Design, synthesis and biological activity as potent anti-bacterial agents against MRSA.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Benzothiazoles; Biofilms; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Urea | 2022 |
Updates on Chlamydia.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Humans; Ofloxacin | 1992 |
[In vitro activity of sparfloxacin against mycoplasmas].
Topics: Culture Media; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; In Vitro Techniques; Mycoplasma; Mycoplasma fermentans; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Ureaplasma urealyticum | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Ofloxacin | 1992 |
[Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Topics: Chlamydia trachomatis; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Humans; In Vitro Techniques; Minocycline; Ofloxacin; Pefloxacin; Roxithromycin; Spiramycin | 1992 |
Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
Topics: Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Tetracycline | 1991 |
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra | 1990 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes.
Topics: Animals; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Erythromycin; Guinea Pigs; Legionella; Legionnaires' Disease; Ofloxacin; Phagocytes; Pulmonary Alveoli | 1988 |
Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Clindamycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Oxazines | 1987 |
Influence of antibiotics on intestinal mucin in healthy subjects.
Topics: Administration, Oral; Adult; Ampicillin; Anti-Bacterial Agents; Bacitracin; Clindamycin; Doxycycline; Drug Combinations; Electrophoresis, Agar Gel; Erythromycin; Feces; Germ-Free Life; Humans; Intestinal Mucosa; Intestines; Metronidazole; Mucins; Nalidixic Acid; Ofloxacin; Oxazines; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Antimycoplasmal activity of ofloxacin (DL-8280).
Topics: Anti-Bacterial Agents; Erythromycin; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Oxazines; Tetracyclines | 1983 |
Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Time Factors | 1995 |
[Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae from clinical specimens].
Topics: Cefaclor; Drug Resistance, Microbial; Erythromycin; Humans; Ofloxacin; Oxacillin; Penicillin Resistance; Serotyping; Streptococcus pneumoniae | 1995 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
[Electron microscopic studies of the action of erythromycin, doxycycline and ofloxacin on the growth cycle of Chlamydia trachomatis].
Topics: Cell Division; Chlamydia trachomatis; Doxycycline; Erythromycin; In Vitro Techniques; Microscopy, Electron; Ofloxacin | 1994 |
The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Minocycline; Ofloxacin; Propionibacterium acnes; Staphylococcus epidermidis | 1994 |
Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Therapy, Combination; Erythromycin; Humans; Legionnaires' Disease; Male; Middle Aged; Ofloxacin; Rifampin | 1993 |
Plasmid profiles and antimicrobial susceptibility of Campylobacter jejuni isolated from Israeli children with diarrhea.
Topics: Amoxicillin; Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Child; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Erythromycin; Furazolidone; Humans; Israel; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
[Multicenter study of the in vitro sensitivity of genital mycoplasmas to antibiotics].
Topics: Clindamycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Humans; In Vitro Techniques; Josamycin; Lymecycline; Male; Minocycline; Mycoplasma; Ofloxacin; Ureaplasma urealyticum; Virginiamycin | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Cricetinae; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Humans; Lung; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Pneumonia, Mycoplasma; Quinolones | 1993 |
Activity of new 4-quinolones in combination with erythromycin or tetracycline against S. pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Quinolones; Spiro Compounds; Streptococcus pneumoniae; Tetracycline | 1995 |
[Immunotropic activity of antimicrobial agents used in tuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Cefotaxime; Cephalosporins; Erythromycin; Isoniazid; Macrophages; Mice; Ofloxacin; Time Factors; Tuberculosis | 1996 |
[Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia trachomatis; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; In Vitro Techniques; Ofloxacin | 1996 |
The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Lactams; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Streptococcus; Streptococcus pneumoniae; Time Factors; Vancomycin | 1996 |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 1996 |
Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host.
Topics: Aged; Anti-Infective Agents; Ceftriaxone; Drug Therapy, Combination; Erythromycin; Humans; Immunocompetence; Legionella; Legionellosis; Male; Ofloxacin; Pneumonia, Bacterial; Rifampin | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
In vitro activity of trovafloxacin against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Erythromycin; Humans; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Monocytes; Ofloxacin; Opsonin Proteins; Rifampin | 1997 |
Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results | 1998 |
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 1998 |
Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Ceftizoxime; Cell Line; Colony Count, Microbial; Dose-Response Relationship, Drug; Erythromycin; Humans; Legionella pneumophila; Macrophages; Microbial Sensitivity Tests; Ofloxacin | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dermatitis; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Hospitalization; Humans; Leg Ulcer; Ofloxacin; Oxacillin; Pemphigoid, Bullous; Penicillin Resistance; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Psoriasis; Retrospective Studies; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child; Child, Preschool; Cholera; Disease Outbreaks; Drug Resistance, Microbial; Erythromycin; Female; Gastroenteritis; Humans; Infant; Infant, Newborn; Male; Nalidixic Acid; Ofloxacin; Pakistan; Prevalence; Sanitation; Tetracycline Resistance; Vibrio cholerae; Water Supply | 1998 |
Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Therapy, Combination; Erythromycin; Humans; In Vitro Techniques; Legionella pneumophila; Levofloxacin; Monocytes; Ofloxacin; Rifampin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.
Topics: Anti-Infective Agents; Ciprofloxacin; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Piperazines; Ureaplasma urealyticum | 1999 |
Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycoplasma hominis; Ofloxacin; Ureaplasma urealyticum | 1999 |
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Contraindications; Doxycycline; Erythromycin; Female; Humans; Male; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Urethritis | 1999 |
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases)
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlortetracycline; Contact Tracing; Demeclocycline; Doxycycline; Drug Therapy, Combination; Erythromycin; Humans; Male; Ofloxacin; Recurrence; Tetracycline; Urethritis | 1999 |
Association of chronic urinary symptoms in women and Ureaplasma urealyticum.
Topics: Adolescent; Adult; Aged; Azithromycin; Bacteriological Techniques; Bacteriuria; Chronic Disease; Cystitis, Interstitial; Doxycycline; Erythromycin; Female; Humans; Middle Aged; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urination Disorders | 2000 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis | 2000 |
Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Monocytes; Ofloxacin | 2000 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Sepsis; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Vancomycin | 2000 |
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Biological Transport; Carrier Proteins; Drug Resistance, Microbial; Erythromycin; Humans; Membrane Transport Proteins; Ofloxacin; Pseudomonas aeruginosa; Tetracycline; Tetracycline Resistance | 2000 |
In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma hominis; Naphthyridines; Ofloxacin; Ureaplasma urealyticum | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Erythromycin; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Ofloxacin; Probenecid; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Tumor Cells, Cultured; Uricosuric Agents; Vincristine | 2001 |
Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cecum; Chickens; Drug Resistance, Microbial; Erythromycin; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Penicillins; Poultry Diseases; Tetracycline | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus | 2001 |
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Gentamicins; Levofloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Ofloxacin; Quinolines; Quinolizines; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Topoisomerase II Inhibitors | 2002 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Antibiotic ophthalmic solutions evaluated by pharmacokinetic parameters of maximum concentration in the aqueous].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Aqueous Humor; Cefmenoxime; Chloramphenicol; Erythromycin; Gentamicins; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Rabbits; Sulbenicillin | 2002 |
Tensions in antibiotic prescribing.
Topics: Anti-Bacterial Agents; Attitude of Health Personnel; Drug Resistance, Microbial; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Health Policy; Humans; Infection Control Practitioners; Ofloxacin; Physicians, Family; Practice Patterns, Physicians'; Public Health; United States | 2002 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
Topics: Adult; Aged; Amitriptyline; Anti-Bacterial Agents; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clarithromycin; Cohort Studies; Drug Prescriptions; Drug Synergism; Erythromycin; Female; Fluoxetine; Heart Conduction System; Humans; Male; Middle Aged; Ofloxacin; Outpatients; Polypharmacy; Torsades de Pointes; United States | 2003 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
Genital mycoplasmas in women attending a family planning clinic in Guiné-Bissau and their susceptibility to antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple; Erythromycin; Female; Guinea-Bissau; Humans; Mycoplasma hominis; Mycoplasma Infections; Ofloxacin; Tetracycline; Ureaplasma Infections; Ureaplasma urealyticum; Vaginosis, Bacterial | 2003 |
[Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Levofloxacin; Ofloxacin; Penicillins; Retrospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Simultaneous detection of mutations associated with resistance to macrolides and quinolones in Campylobacter jejuni and C. coli using a PCR-line probe assay.
Topics: Campylobacter coli; Campylobacter jejuni; Drug Resistance, Bacterial; Erythromycin; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction | 2003 |
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cell Line; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; Legionella; Legionnaires' Disease; Levofloxacin; Macrophages; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 2003 |
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline | 2004 |
Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Topics: Adult; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Female; Fluorescent Antibody Technique, Direct; Humans; Male; Microbial Sensitivity Tests; Mycoplasma hominis; Mycoplasma Infections; Ofloxacin; Prevalence; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urethra; Urethritis | 2004 |
[Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; China; Chloramphenicol; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Rifampin; Streptococcus pneumoniae; Tetracycline; Trimethoprim | 2004 |
Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection.
Topics: Animals; Anti-Bacterial Agents; Brucella abortus; Brucellosis; Drug Therapy, Combination; Erythromycin; Levofloxacin; Male; Mice; Ofloxacin; Rifampin; Treatment Outcome | 2004 |
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Child; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Randomized Controlled Trials as Topic; Time Factors | 2004 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Population Surveillance; Prevalence; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 2004 |
In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Erythromycin; Humans; Legionella pneumophila; Microbial Sensitivity Tests; Ofloxacin; Thiamphenicol | 2004 |
In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Chlamydia trachomatis; Doxycycline; Drug Antagonism; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Ofloxacin; Spectinomycin | 2005 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Topics: Anti-Bacterial Agents; Aza Compounds; Dose-Response Relationship, Drug; Erythromycin; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Legionella; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines | 2005 |
Sourcing faecal pollution from onsite wastewater treatment systems in surface waters using antibiotic resistance analysis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cephalothin; Chlortetracycline; Colony Count, Microbial; Discriminant Analysis; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Feces; Gentamicins; Humans; Moxalactam; Ofloxacin; Tetracycline; Water Microbiology; Water Pollution | 2005 |
The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Topics: Anti-Bacterial Agents; Cell Adhesion Molecules; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Flow Cytometry; Humans; Levofloxacin; Ofloxacin; Phlebitis; Virginiamycin | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.
Topics: Alleles; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance; Erythromycin; Genes, Bacterial; Genetic Variation; Hospitals; Humans; Levofloxacin; Medical Records; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Ofloxacin; Pneumococcal Infections; Retrospective Studies; Spain; Species Specificity; Streptococcus pyogenes; Superantigens; Tetracycline; Urban Population | 2006 |
Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Chloramphenicol; Chromatography, High Pressure Liquid; Climate; Erythromycin; Hong Kong; Macrolides; Norfloxacin; Ofloxacin; Quinolones; Rivers; Seasons; Seawater; Spectrometry, Mass, Electrospray Ionization; Sulfanilamides; Time Factors; Waste Management; Water Pollutants, Chemical | 2007 |
[Antibiotic resistance in Streptococcus pneumoniae strains isolated from sterile body sites].
Topics: Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Dacryocystitis; Drug Resistance, Bacterial; Ear, Middle; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Pleural Effusion; Pneumococcal Infections; Streptococcus pneumoniae; Synovial Fluid; Wound Infection | 2006 |
Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.
Topics: Animals; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Fibroblasts; Humans; Infusions, Intravenous; Inhibitory Concentration 50; Levofloxacin; Mice; No-Observed-Adverse-Effect Level; Ofloxacin; Phlebitis; Reproducibility of Results; Toxicity Tests; Virginiamycin | 2007 |
Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biliary Tract Diseases; Case-Control Studies; Chemoembolization, Therapeutic; Drainage; Drug Therapy, Combination; Erythromycin; Humans; Levofloxacin; Liver Abscess; Liver Function Tests; Metronidazole; Neomycin; Ofloxacin; Retrospective Studies; Risk Factors; Stents | 2006 |
[Streptococcus agalactiae isolated in Santa Fe, Argentina: antibiotic susceptibility and erythromycin-clindamycin resistance mechanisms].
Topics: Ampicillin; Argentina; Bacterial Proteins; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Humans; Methyltransferases; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Polymerase Chain Reaction; Streptococcal Infections; Streptococcus agalactiae | 2007 |
Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005).
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefuroxime; Cephalosporin Resistance; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Paranasal Sinuses; Penicillin Resistance; Population Surveillance; Streptococcus pneumoniae; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bile; Biological Transport; Cimetidine; Cyclosporine; Diclofenac; Enzyme Inhibitors; Erythromycin; Liver; Male; Membrane Transport Proteins; Ofloxacin; Probenecid; Rats; Rats, Sprague-Dawley; Uricosuric Agents | 2007 |
Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cost-Benefit Analysis; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Humans; Markov Chains; Metronidazole; Ofloxacin; Pelvic Inflammatory Disease | 2007 |
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blood; Cefotaxime; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oxacillin; Pneumococcal Infections; Serotyping; Spain; Sputum; Streptococcus pneumoniae | 2009 |
Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Erythromycin; Gene Deletion; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pyogenes | 2009 |
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Cohort Studies; Community-Acquired Infections; Comorbidity; Erythromycin; Female; France; Hospital Mortality; Hospitals, University; Humans; Legionella; Legionnaires' Disease; Lung Diseases, Fungal; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Rifampin; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2010 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin.
Topics: Acetylcysteine; Amoxicillin; Anti-Bacterial Agents; Biofilms; Erythromycin; Humans; Ibuprofen; Levofloxacin; Ofloxacin; Serum Albumin; Streptococcus pneumoniae | 2010 |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2010 |
Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Typing Techniques; Erythromycin; Humans; Legionella; Legionellosis; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Ofloxacin; Serotyping; Tigecycline; Time Factors | 2011 |
In vitro activities of erythromycin, tetracycline and levofloxacin alone and in dual combinations against ureaplasma spp.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Erythromycin; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Tetracycline; Ureaplasma; Ureaplasma Infections | 2011 |
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; China; Chloramphenicol; Drug Utilization; Environmental Monitoring; Erythromycin; Fluoroquinolones; Hong Kong; Humans; Macrolides; Ofloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
[Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Hungary; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma hominis; Ofloxacin; Sexual Behavior; Sexually Transmitted Diseases, Bacterial; Ureaplasma urealyticum; Urogenital System | 2011 |
In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE model methods.
Topics: Anti-Bacterial Agents; Benzofurans; Clindamycin; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Oxacillin | 2012 |
Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Levofloxacin; Ofloxacin; Penicillins; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Serotyping; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Clindamycin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Levofloxacin; Middle Aged; Mutation; Ofloxacin; Prevalence; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline | 2013 |
Evaluation of methicillin-resistant Staphylococcus aureus nasal carriage in Malagasy patients.
Topics: Adolescent; Adult; Carrier State; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Hospitalization; Humans; Madagascar; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nose; Ofloxacin; Prevalence; Risk Factors; Staphylococcal Infections; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2013 |
Impact of certain household micropollutants on bacterial behavior. Toxicity tests/study of extracellular polymeric substances in sludge.
Topics: Erythromycin; Escherichia coli; Ibuprofen; Ofloxacin; Phenols; Polycyclic Compounds; Sewage; Toxicity Tests; Triclosan; Wastewater; Water Pollutants, Chemical | 2013 |
Occurrence of eight household micropollutants in urban wastewater and their fate in a wastewater treatment plant. Statistical evaluation.
Topics: Alkanesulfonic Acids; Caprylates; Cities; Environmental Monitoring; Erythromycin; Fluorocarbons; Housing; Ibuprofen; Ofloxacin; Phenols; Sucrose; Triclosan; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical | 2014 |
Prevalence and detection of antibiotic-resistant determinant in Salmonella isolated from food-producing animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalothin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Food Microbiology; Foodborne Diseases; Goats; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Polymerase Chain Reaction; Salmonella; Salmonella Infections; South Africa; Tetracycline | 2015 |
Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Genitalia, Female; Genitalia, Male; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mycoplasma hominis; Mycoplasma Infections; Ofloxacin; Polymerase Chain Reaction; Quinolones; Ribosomal Proteins; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Switzerland; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum | 2015 |
Levels of six antibiotics used in China estimated by means of wastewater-based epidemiology.
Topics: Anti-Bacterial Agents; China; Cities; Erythromycin; Norfloxacin; Ofloxacin; Trimethoprim; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical | 2016 |
Orbital cellulitis and multiple abscess formation after strabismus surgery.
Topics: Abscess; Administration, Topical; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Drug Therapy, Combination; Erythromycin; Exotropia; Eye Infections, Bacterial; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Oculomotor Muscles; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Cellulitis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
[Donovanosis (granuloma inguinale)].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Granuloma Inguinale; Humans; Ofloxacin | 2016 |
An automated on-line turbulent flow liquid-chromatography technology coupled to a high resolution mass spectrometer LTQ-Orbitrap for suspect screening of antibiotic transformation products during microalgae wastewater treatment.
Topics: Anti-Bacterial Agents; Biotransformation; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Macrolides; Microalgae; Ofloxacin; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical; Water Purification | 2018 |
Electrochemical degradation of antibiotics using flow-through graphene sponge electrodes.
Topics: Anti-Bacterial Agents; Electrodes; Erythromycin; Graphite; Ofloxacin; Oxidation-Reduction; Sulfamethoxazole; Trimethoprim; Water; Water Pollutants, Chemical | 2022 |
Contamination, transport, and ecological risks of pharmaceuticals and personal care products in a large irrigation region.
Topics: Caffeine; China; Cosmetics; Ecosystem; Environmental Monitoring; Erythromycin; Humans; Norfloxacin; Ofloxacin; Pharmaceutical Preparations; Risk Assessment; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
Antibiotics in sewage treatment plants, receiving water bodies and groundwater of Chennai city and the suburb, South India: Occurrence, removal efficiencies, and risk assessment.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Environmental Monitoring; Erythromycin; Fluoroquinolones; Groundwater; India; Macrolides; Ofloxacin; Risk Assessment; Sewage; Sulfamethazine; Tetracyclines; Water; Water Pollutants, Chemical | 2022 |
A new probiotic Lactobacillus plantarum strain isolated from traditional dairy together with nanochitosan particles shows the synergistic effect on aflatoxin B1 detoxification.
Topics: Aflatoxin B1; Anti-Bacterial Agents; Chitosan; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lactobacillales; Lactobacillus plantarum; Nalidixic Acid; Neomycin; Ofloxacin; Probiotics; Vancomycin | 2022 |
A high-precision prediction for spatiotemporal distribution and risk assessment of antibiotics in an urban watershed using a hydrodynamic model.
Topics: Anti-Bacterial Agents; China; Enrofloxacin; Environmental Monitoring; Erythromycin; Humans; Hydrodynamics; Manure; Norfloxacin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sewage; Sulfamethoxazole; Water Pollutants, Chemical | 2022 |
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing].
Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry | 2023 |